
GC35694
CID 16020046
Also known as 4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1,4-dihydropyrrolo[3,4-d]pyrazol-5-yl]benzoic acid
CID 16020046 is a potent and selective GPR55 antagonist and inhibits GPR55 constitutive activity with an IC50 of 0·15 μM· CID 16020046 inhibits GPR55-mediated Ca2+ signaling and GPR55-mediated ERK1/2 phosphorylation· CID 16020046 reduces wound healing in endothelial cells and is involved in the regulation of platelet function
ChemicalCAS834903-43-4MW425.44FormulaC25H19N3O4
- CAS number
- 834903-43-4
- Molecular weight
- 425.44
- Formula
- C25H19N3O4
- Solubility
- DMSO: 100 mg/mL (235·05 mM)
- InChIKey
- VGUQVYZXABOXCX-UHFFFAOYSA-N
- Catalogue number
- GC35694
- Brand
- GLPBIO
Computed properties PubChem CID 16020046 · XLogP 4 · TPSA 107 Ų · H-bond donors 3
- XLogP
- 4
- TPSA
- 107 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 32
SMILES CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(=O)O)C5=CC(=CC=C5)O
Computed descriptors from PubChem (CID 16020046), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il